News — Department of Oncology

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Characterising an insulin-like growth factor (IGF) signature for early detection/risk reduction of cancer

30 November 2018

Researchers in the Department of Oncology have secured funding to characterise an insulin-like growth factor (IGF) signature for early detection and risk reduction of cancer.

Cookies on this website

Search results (1)

Characterising an insulin-like growth factor (IGF) signature for early detection/risk reduction of cancer